Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35M Buy
28,300
+14,900
+111% +$1.28M ﹤0.01% 4826
2025
Q4
$1.15M Hold
13,400
﹤0.01% 5452
2025
Q3
$1.12M Buy
13,400
+9,400
+235% +$858K ﹤0.01% 5473
2025
Q2
$405K Hold
4,000
﹤0.01% 6189
2025
Q1
$425K Sell
4,000
-2,400
-38% -$249K ﹤0.01% 5976
2024
Q4
$701K Sell
6,400
-15,000
-70% -$1.75M ﹤0.01% 5608
2024
Q3
$3.1M Sell
21,400
-25,000
-54% -$3.41M ﹤0.01% 3550
2024
Q2
$6.77M Buy
46,400
+15,000
+48% +$2.1M ﹤0.01% 2561
2024
Q1
$4.52M Buy
31,400
+25,000
+391% +$2.85M ﹤0.01% 3081
2023
Q4
$598K Hold
6,400
﹤0.01% 4954
2023
Q3
$565K Buy
+6,400
New +$658K ﹤0.01% 4569
2015
Q1
Sell
-6,500
Closed -$81K 8895
2014
Q4
$81K Buy
+6,500
New +$80.4K ﹤0.01% 5923

Other funds holding CROX

UBS Group's CROX Position: Q1 2026 in Review

UBS Group reduced its Crocs (CROX) stake by 25% in Q1 2026, selling an estimated $19.7M and leaving 696,755 shares worth $57.8M. The position accounts for 0.01% of the portfolio, ranked #1503.

UBS Group first reported a position in CROX in Q4 2014 and has held it in 46 quarters since. The position peaked at $128M in Q4 2024. 457 funds tracked by Wall St. Rank hold CROX as of Q1 2026.

  • UBS Group held 696,755 shares of Crocs worth $57.8M as of Q1 2026.
  • UBS Group sold 229,772 Crocs shares in Q1 2026, an estimated $19.7M.
  • Crocs made up 0.01% of UBS Group's portfolio in Q1 2026, its #1503 holding.
  • UBS Group first reported a position in Crocs in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Crocs position peaked at $128M in Q4 2024.
  • 457 funds tracked by Wall St. Rank held Crocs as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.